SEC Tracker
Get the app

AbbVie ABBV

AbbVie expands board with new director

Form
8-K
Filed
Importance
Major
  1. Board expanded to 13 directors
  2. Dr. John M. Carethers appointed as Class II director
  3. Dr. Carethers joins Public Policy and Sustainability Committee
  4. Compensation details in 10-Q for Q1 2025

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when AbbVie files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float over $2B, nearest public float first, as each company reports it on its annual report cover.

  1. Johnson & Johnson JNJ public float $367.0B, Jun 29, 2025
  2. Abbott Laboratories ABT public float $232.2B, Jun 30, 2025
  3. Merck MRK public float $198.1B, Jun 30, 2025
  4. Pfizer PFE public float $138.0B, Jun 29, 2025
  5. Vertex Pharmaceuticals VRTX public float $113.4B, Jun 30, 2025